FDA’s ‘Radical’ Abortion Pill Stance Fails, 5th Circ. Told

By Hannah Albarazi (May 9, 2023, 10:15 PM EDT) — Anti-abortion groups challenging the U.S. Food and Drug Administration’s approval of mifepristone in 2000 slammed the agency’s allegedly “decades-long pattern of delay and obfuscation” and urged the Fifth Circuit to uphold a Texas ruling that would have blocked access to the common abortifacient last month had the U.S. Supreme Court not intervened….

Read more